Nuzenio

Urology Times

Urology Times entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 18 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC - Urology TimesUrology Times · Sat, 08 Aug 2026 17:49:18 GMTKeith Xavier, MD, URPS, shares early experience with Altaviva for male urge incontinence - Urology TimesUrology Times · Fri, 07 Aug 2026 18:55:18 GMTElizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab - Urology TimesUrology Times · Fri, 07 Aug 2026 17:34:09 GMTAdam B. Murphy, MD, MBA, MSCI, urges thoughtful AI integration to prevent clinician burnout - Urology TimesUrology Times · Thu, 06 Aug 2026 21:05:00 GMTNeil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer - Urology TimesUrology Times · Thu, 06 Aug 2026 15:33:15 GMTCAPItello-281 Trial Design and Efficacy Data in mHSPC - Urology TimesUrology Times · Thu, 06 Aug 2026 12:08:03 GMTJoshua Lang, MD, MS, on matching treatment intensity to tumor biology - Urology TimesUrology Times · Wed, 05 Aug 2026 20:55:00 GMTTrial to evaluate ivonescimab plus enfortumab vedotin in urothelial carcinoma - Urology TimesUrology Times · Wed, 05 Aug 2026 18:53:01 GMT

Timeline

Sat, 08 Aug 2026 17:49:18 GMTPublished data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC - Urology Times
Fri, 07 Aug 2026 18:55:18 GMTKeith Xavier, MD, URPS, shares early experience with Altaviva for male urge incontinence - Urology Times
Fri, 07 Aug 2026 17:34:09 GMTElizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab - Urology Times
Thu, 06 Aug 2026 21:05:00 GMTAdam B. Murphy, MD, MBA, MSCI, urges thoughtful AI integration to prevent clinician burnout - Urology Times
Thu, 06 Aug 2026 15:33:15 GMTNeil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer - Urology Times
Thu, 06 Aug 2026 12:08:03 GMTCAPItello-281 Trial Design and Efficacy Data in mHSPC - Urology Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Urology Times.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.